Bioalmanac
Tesamorelin / Ipamorelin
Tesa ipa · Tesa/Ipa blend · tesamorelin with ipamorelin
An approved GHRH analogue paired with a ghrelin agonist. Sold at three different splits, which matters more here than in most blends.
Storage
- Freeze-dried powder
- Refrigerated at 2–8 °C, protected from light.
- After mixing
- Refrigerated at 2–8 °C and used within about 30 days. A blend cannot be split. A contaminated vial takes every component with it.
- Long-term, frozen
- Unopened powder is stable at −20 °C or colder.
Reconstitution — 10 mg vial, 300 mcg dose
On a 1 mL U-100 syringe. Check every figure against your own vial before drawing.
| Water added | Concentration | Volume to draw | Units | Doses per vial |
|---|---|---|---|---|
| 1 mL | 10 mg/mL | 0.03 mL | 3 units | 33.3 |
| 2 mL | 5 mg/mL | 0.06 mL | 6 units | 33.3 |
| 3 mL | 3.333 mg/mL | 0.09 mL | 9 units | 33.3 |
| 5 mL | 2 mg/mL | 0.15 mL | 15 units | 33.3 |
Dose ranges reported in sources
Descriptions of what sources report, not recommendations.
| Goal | Range | Frequency | Source |
|---|---|---|---|
| Commonly described community protocol | 300–500 mcg | Once daily before bed, 5 days a week | Community practice |
When to stop
- Any allergic response: rash, hives, facial swelling or difficulty breathing. Seek urgent care.
- Persistent numbness or tingling in the hands.
- New or worsening joint swelling.
Use your browser’s print dialog and choose “Save as PDF”. This block is hidden when printed.